ANNOUNCEMENTS: We are pleased to inform you that the Follistatin gene transfer for inclusion-body myositis has cleared its last regulatory hurdle and recruitment of patients begins this December. The trial to be conducted at Nationwide Children’s Hospital in Columbus, OH expects to select patients in December to be enrolled, with the first patient injection to begin in January, 2012. The group at Nationwide Children’s have worked hard to begin what we hope will be helpful to patients with sIBM to improve muscle strength. TMA will keep in touch with the investigators regarding the progress of the trial. Should you have any questions about the trial or patient recruitment, please contact Xiomara Rosales-Quintero at Xiomara.Rosales-Quintero@nationwidechildrens.org.
Receive the Latest News from Johns Hopkins Rheumatology
Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.
